Literature DB >> 16845236

Individual-level predictors for HIV testing among antenatal attendees in Lusaka, Zambia.

Sara Thierman1, Benjamin H Chi, Jens W Levy, Moses Sinkala, Robert L Goldenberg, Jeffrey S A Stringer.   

Abstract

Despite the availability of antiretroviral prophylaxis, roughly one-fifth of public-sector antenatal patients decline HIV testing in Lusaka, Zambia. We administered a survey to determine individual-level predictors of HIV testing. Of 1064 antenatal attendees approached after pretest counseling, 1060 (>99%) participated. Of these, 686 (65%) agreed to HIV testing. On bivariate analysis controlling for clinic of attendance, women younger than 20 years old (adjusted RR [ARR] = 1.14), unmarried (ARR = 1.14), pregnant for the first time (ARR = 1.14), with lower educational attainment (ARR = 1.15), and with lower income (ARR = 1.14) were all more likely to undergo testing. When HIV risk was considered, women with low self-perceived risk were most likely to undergo HIV testing. As risk perception increased, likelihood for testing decreased (P for trend < 0.001). Although not statistically predictive, we identified prevalent community beliefs that may act as barriers to testing. Because individual-level characteristics were only weakly predictive of HIV testing, future work should concentrate on community-level factors.

Entities:  

Mesh:

Year:  2006        PMID: 16845236     DOI: 10.1097/00000441-200607000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  10 in total

Review 1.  Women's willingness to be tested for human immunodeficiency virus during pregnancy: A review.

Authors:  Merav Ben-Natan; Yelena Hazanov
Journal:  World J Virol       Date:  2015-08-12

2.  Barriers and facilitators of antiretroviral therapy adherence in rural Eastern province, Zambia: the role of household economic status.

Authors:  Rainier Masa; Gina Chowa; Victor Nyirenda
Journal:  Afr J AIDS Res       Date:  2017-06-22       Impact factor: 1.300

3.  Behavior and health beliefs as predictors of HIV testing among women: a prospective study of observed HIV testing.

Authors:  Hao Fan; Kenneth H Fife; Dena Cox; Anthony D Cox; Gregory D Zimet
Journal:  AIDS Care       Date:  2018-02-22

4.  Burnout and use of HIV services among health care workers in Lusaka District, Zambia: a cross-sectional study.

Authors:  Gina R Kruse; Bushimbwa Tambatamba Chapula; Scott Ikeda; Mavis Nkhoma; Nicole Quiterio; Debra Pankratz; Kaluba Mataka; Benjamin H Chi; Virginia Bond; Stewart E Reid
Journal:  Hum Resour Health       Date:  2009-07-13

5.  Who will Benefit from a Wide-Scale Introduction of Vaginal Microbicides in Developing Countries?

Authors:  Dobromir T Dimitrov; Benoit Masse; Marie-Claude Boily
Journal:  Stat Commun Infect Dis       Date:  2010-01

6.  Factors Associated with Readiness to VCT Service Utilization among Pregnant Women Attending Antenatal Clinics in Northwestern Ethiopia: A Health Belief Model Approach.

Authors:  Zinash Moges; Alemayehu Amberbir
Journal:  Ethiop J Health Sci       Date:  2011-08

7.  Availability of supplies and motivations for accessing voluntary HIV counseling and testing services in Blantyre, Malawi.

Authors:  Bwanali H Jereni; Adamson S Muula
Journal:  BMC Health Serv Res       Date:  2008-01-23       Impact factor: 2.655

8.  Self-reported non-receipt of HIV test results: A silent barrier to HIV epidemic control in Mozambique.

Authors:  Didier Mugabe; Nilesh Bhatt; James G Carlucci; Eduardo S Gudo; Wu Gong; Mohsin Sidat; Troy D Moon
Journal:  PLoS One       Date:  2019-10-22       Impact factor: 3.240

Review 9.  Which Psychological Factors are Related to HIV Testing? A Quantitative Systematic Review of Global Studies.

Authors:  Michael Evangeli; Kirsten Pady; Abigail L Wroe
Journal:  AIDS Behav       Date:  2016-04

Review 10.  Facilitators and barriers for HIV-testing in Zambia: A systematic review of multi-level factors.

Authors:  Shan Qiao; Yao Zhang; Xiaoming Li; J Anitha Menon
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.